BlackRock Greater Europe Investment Trust plc (LON:BRGE) is the topic of conversation when Edison Investment Research Managing Director Rob Murphy caught up with DirectorsTalk for an exclusive interview.
Q1: Rob, could you describe or discuss BlackRock Greater Europe Investment Trust’s philosophy and processes?
A1: So, Edison just put out a note the 19th of November which was titled ‘Philosophy and process shining through’ so it’s a good place to start with that.
BRGE is really focused on capital growth, it’s an all-cap fund so it looks at both larger and smaller accounts and it’s pretty focused so about 30 to 45 names typically, and they look at both developed Europe and also some emerging European countries.
It’s managed by Stefan Gries who does the developed part of the portfolio and Sam Vecht who manages the emerging European parts and they’re backed up by the BlackRock equity team which has 21 investment professionals. Obviously, they have access to the whole of BlackRock’s group resources and corporate access which is very important for them because they like to see companies and, obviously ask them all the important questions they need to know.
The focus of the companies themselves is very quality driven, they look at good balance sheets, strong management that has demonstrated an ability to grow that can articulate well what their strategy is. They focused on companies that deliver high returns on capital but then they’ll also have the options to deploy that capital using strong free cash flow to fund further sustainable growth.
They like something extra in the companies they managed, some special feature could be a desirable or unique product, brand, certain types of contract structures and they take a longer-term view which allows them to capture the underappreciated earnings power of these kinds of companies.
They also employ a very constant process monitoring the positions they have, every position is competing against the others for their capital so they always want to make sure they have the conviction best ideas in there. They will exercise sell discipline if information changes or if performance and valuation becomes too high for them so that’s basically the process they’re using.
Q2: How has the trust perform versus the European market and its peers in the AIC Europe sector?
A2: So, it’s been a good performer, as people know growth has been a good sector to be in in the markets, but they’ve actually demonstrated good performance over the longer term, not just more recently.
The trust in terms of NAV total return has outperformed the relevant Europe Ex UK indices over one, three, five, ten years and since inception back in September 2004 and relative to the peer group in the AIC, it’s basically number one in greater than three, five, ten years. It’s number two over one year so just pipped by one of the fund over one year so you can see it’s been a very consistently performing fund.
Q3: Now, you touched on the managers earlier, are BRGE managers constructive on the outlook for European equities?
A3: Yes, I think they are. We’ve seen obviously a few very positive developments coming through on COVID, we have now a number of very strong vaccine candidates now and Europe has responded with the €750 billion recovery fund which is a very significant development. That will support a number of investments that the company can actually benefit from too, especially in moving to a lower carbon future, biofuels, electric vehicles and so forth.
Having that fund behind the block is expected to reduce the risk premium on European equities and in a way, it’s helping consolidate the fiscal picture across Europe so a lot of that money will help some of the Southern European countries and could be quite significant for those.
I think the managers would also stress that you don’t have to be hugely optimistic on Europe itself to find very good companies that that can perform well because many of our companies have global brands, a lot of foreign revenues and have, again, as I said, unique products or features which attracts the company to those companies.
So, overall, they’re constructive, we saw evidence actually of the pickup in summer when we had some easing of lockdowns across Europe so there was quite a big pickups, it’s come back the other way a bit recently.
I think that’s given us a picture of what we should hopefully be able to move into next year as we get through the spring and hopefully the vaccines get rolled out.
Q4: You hinted at the portfolio earlier, could you highlight the structure of the BlackRock Greater Europe Investment Trust portfolio and some of the more recent transactions?
A4: As I said, the portfolio is pretty concentrated, the top 10 positions are about 45% of the portfolio and in terms of positioning by sector, it’s very overweight technology, that’s 15% above the benchmark, industrials and consumer services, and also a little bit on the healthcare side.
Where they’re underweight is on the consumer goods side, financials, utilities, and basic materials so they have that tilt in there and they would probably, if you look at the note, they will categorise the portfolio maybe into three areas with regards to sort of COVID.
You’ve got the resilient companies which would be things like DSV or Royal Unibrew in Denmark and there’s those that benefit from COVID such as Lonza which is contract drug manufacturing. Then there’s those that are suffering a bit typically because of less travel, which would be Safran which is aerospace and Amadeus which is travel technology but they reviewed those positions and they’re very happy to keep those on and, obviously, they’ll benefit as we get recovery coming through.
In terms of sort of what they’ve been adding so new companies they’ve added has been in the technology sector, Netcompany Group in Denmark, that’s an IT services business, the Danish government is a customer and they’re helping people digitise effectively so moving processes from paper to digital processes. There’s billions of tax documents need digitising for instance.
Another one would be ALD Automotive in France which is a corporate fleet leasing business, fears over writing down the fleet because of diesel had been over egged and 20% of the fleet is now electrical hybrid. So, although that’s a small cap, those kinds of companies can fit into this strategy. It’s on a Pe of 8, it makes a return on equity of 15 and of course, because you’re an investment trust, you can hold smaller, less liquid names because you don’t have the flows that you get through open-ended vehicles.
As a result of COVID, Stratec Biomedical Systems in Germany, basically upgraded guidance twice, it experienced supernormal demand from COVID so there was less potential for those upgrades to come through and it was no longer attractively valued. So that’s an example of something that they sold.
